Expression of LOX-1, an oxidized low-density lipoprotein receptor, in choroidal neovascularization

Archives of Ophthalmology

Volumn 122, Issue 12, 2004, Pages 1873-1876

  Honjo, Megumi ^a   Sawamura, Tatsuya ^a   Hinagata, Junichi ^a   Nakamura, Kayo ^a   Sanada, Nobuhito ^a   Tanihara, Hidenobu ^a   Honda, Yoshihito ^a   Kiryu, Junichi ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

LECTINLIKE OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR TYPE 1; LOW DENSITY LIPOPROTEIN RECEPTOR; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; CELLULAR DISTRIBUTION; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CRYOPRESERVATION; ENDOTHELIUM CELL; EXCISION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERLIPIDEMIA; IMMUNOHISTOCHEMISTRY; LIPID ANALYSIS; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STROMA; SUBRETINAL NEOVASCULARIZATION; VASCULAR ENDOTHELIUM;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CHO CELLS; CHOROIDAL NEOVASCULARIZATION; CRICETINAE; CRICETULUS; FEMALE; FLUORESCEIN ANGIOGRAPHY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; MACULAR DEGENERATION; MALE; MEMBRANES; MICE; MICE, INBRED BALB C; MIDDLE AGED; RECEPTORS, LDL; TRANSFECTION;

EID: 10044244815     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.122.12.1873     Document Type: Article

References (12)

1. Vingerling JR, Hofman A, Grobbee DE, de Jong PT. Age-related macular degeneration and smoking: the Rotterdam Study. Arch Ophthalmol 1996;114:1193-1196.
2. Friedman E. The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration. Am J Ophthalmol. 2000;130:658-663.
3. Smith W, Mitchell P, Leeder SR, Wang JJ. Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol 1998;116:583-587.
4. Smith W, Mitchell P, Webb K, Leeder SR. Dietary antioxidants and age-related maculopathy: the Blue Mountains Eye Study. Ophthalmology. 1999;106:761-767.
5. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119:1417-1436.
6. Ikeda T, Obayashi H, Hasegawa G, et al. Para-oxonase gene polymorphisms and plasma oxidized low-density lipoprotein level as possible risk factors for exudative age-related macular degeneration. Am J Ophthalmol. 2001;132:191-195.
7. Penfold PL, Madigan MC, Gillies MC, Provis JM. Immunological and aetiological aspects of macular degeneration. Prog Retin Eye Res. 2001; 20:385-414.
8. Oh H, Takagi H, Takagi C, et al. The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes. Invest Ophthalmol Vis Sci. 1999; 40:1891-1898.
9. Sawamura T, Kume N, Aoyama T, et al. An endothelial receptor for oxidized low-density lipoprotein. Nature. 1997;386:73-77.
10. Nagase M, Abe J, Takahashi K, Ando J, Hirose S, Fujita T. Genomic organisation and regulation of expression of the lectin-like oxidized low-density lipoprotein receptor (LOX-1) gene. J Biol Chem. 1998;273:33702- 33707.
11. Li DY, Chen HJ, Staples ED, et al. Oxidized low-density lipoprotein receptor LOX-1 and apoptosis in human atherosclerotic lesion. J Cardiovasc Pharmacol Ther. 2002;7:147-153.
12. Kataoka H, Kume N, Miyamoto S, et al. Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesion. Circulation. 1999;99:3110-3117.